Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ONESOURCE SPECIALTY PHARMA LTD.

NSE : ONESOURCEBSE : 544292ISIN CODE : INE013P01021Industry : Pharmaceuticals & DrugsHouse : Private

BSE1998.4049.45 (+2.54 %)

PREV CLOSE ( ) 1948.95

OPEN PRICE ( ) 1942.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4521

TODAY'S LOW / HIGH ( )1942.00 2010.00

52 WK LOW / HIGH ( )1163.05 2249.65

NSE2000.3052.1 (+2.67 %)

PREV CLOSE( ) 1948.20

OPEN PRICE ( ) 1947.80

BID PRICE (QTY) 2000.30 (139)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 112627

TODAY'S LOW / HIGH( ) 1940.00 2010.80

52 WK LOW / HIGH ( )1209.95 2248

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 2007

Management Info

- Chairman Neeraj Sharma - Managing Director

Registered Office

Address Unit No. 902, Cyber One,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924

Email cs@stelis.com

Website www.stelis.com

Registrars Details

Not Available

Listing : BSE, NSE

NEWS

16Jun Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed that the Exchange has received t..

11Jun OneSource Specialty Pharma informs abo
In continuation to its earlier intimation dated June 10, 2025, regarding..

11Jun OneSource partners with Xbrane Biophar
OneSource Specialty Pharma and Xbrane Biopharma AB (Xbrane), a Sweden-he..

10Jun Onesource Specialty Pharma informs abo
Onesource Specialty Pharma has informed about the subscription of equity..

10Jun OneSource Specialty Pharma’s Bangalore
OneSource Specialty Pharma’s flagship facility in Bangalore, India, has..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	1741.87	193.1
Gross Profit	1748.77	-214.55
Operating Profit	2408.65	3869.57
Net Sales	4774.14	12995.89

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 34745.50 (1.62%)	M.Cap ( in Cr)73831.76
Gland Pharma (BSE) 2039.40 (4.04%)	M.Cap ( in Cr)33600.42
Procter&Gamble Healt (BSE) 5920.55 (1.00%)	M.Cap ( in Cr)9827.75
Torrent Pharma (BSE) 3554.05 (1.45%)	M.Cap ( in Cr)120285.20
Concord Biotech (BSE) 1946.00 (2.57%)	M.Cap ( in Cr)20358.31

Shareholding Pattern

	PROMOTERS	34.25%
	NON-INSTITUTION	29.3%
	MUTUAL FUNDS/UTI	8.32%
	FI/BANKS/INSURANCE	2.78%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal Manuf...	4.75
Motilal Oswal Focus...	4.48
Motilal Oswal Activ...	3.63
Motilal Oswal ELSS ...	3.27
Motilal Oswal Large...	3.22
JM Focused Fund-Reg(G)	3.11
JM ELSS Tax Saver Fund(G)	2.97

Risk Disclosures on Derivatives

Smart Quotes

ONESOURCE SPECIALTY PHARMA LTD.